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Abstract
Objectives—This is the first systematic review of the effectiveness of barcoding practices for 
reducing patient specimen and laboratory testing identification errors.
Design and Methods—The CDC-funded Laboratory Medicine Best Practices Initiative 
systematic review methods for quality improvement practices were used.
Results—A total of 17 observational studies reporting on barcoding systems are included in the 
body of evidence; 10 for patient specimens and 7 for point-of-care testing. All 17 studies favored 
barcoding, with meta-analysis mean odds ratios for barcoding systems of 4.39 (95% CI: 3.05 – 
6.32) and for point-of-care testing of 5.93 (95% CI: 5.28 – 6.67).
Conclusions—Barcoding is effective for reducing patient specimen and laboratory testing 
identification errors in diverse hospital settings and is recommended as an evidence-based “best 
practice.” The overall strength of evidence rating is high and the effect size rating is substantial. 
Unpublished studies made an important contribution comprising almost half of the body of 
evidence.
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Reduction of medical errors has been a major national priority since the publication of the 
Institute of Medicine report To Err is Human [1]. Patient specimen and laboratory testing 
identification errors have been reported as the leading cause of laboratory errors [2]. 
Identification (ID) errors may result in patient harm and are completely preventable. 
Identifying effective strategies for reducing these errors has been identified as a research 
priority[3], but there are no systematic reviews available providing evidence of effectiveness 
for quality improvement practices. The purpose of this article is to provide a systematic 
review that evaluates whether barcoding practices are effective at reducing patient specimen 
and laboratory testing identification errors. The answer is provided by applying the CDC 
Laboratory Medicine Best Practices Initiative’s (LMBP) systematic review methods for 
quality improvement practices and translating the results into evidence-based guidance [4].
Accurate identification of patients, their specimens and laboratory test results linked to them 
is essential in all healthcare settings for providing effective, safe, timely, efficient, equitable 
and patient-centered healthcare. Systems to monitor errors in patient specimen and 
laboratory testing identification are federally regulated [5], and accurate identification is a 
nationally recognized patient safety priority [6–11]. Although government, accreditation, 
patient safety, professional and industry organizations require laboratories to establish and 
follow policies and procedures to ensure accurate identification from specimen collection to 
result reporting, the guidance provided is largely based on expert opinion. Typical hospital 
clinical laboratories are responsible for thousands of tests daily, yet there is considerable 
uncertainty about how to reduce identification errors, and what quality improvement 
practices are effective [12]. ID error consequences include incorrect, delayed and/or lack of 
treatment which may cause injury, disability, death, longer lengths of stay, and higher 
healthcare costs, as well as other patient harm and diverted resources [13–15]. Accurate 
identification is particularly essential to the safe transfusion of blood products since ID 
errors put patients at risk for adverse outcomes from blood incompatibility [14].
Quality Gap: Patient Specimen and Laboratory Testing Identification Errors
ID errors involve incorrect matching of patient, specimen and/or test information, all of 
which should be unequivocally linked to a correct patient identify throughout the entire 
testing process [7, 13]. There are many causes of ID errors, most of which are associated 
with human error and under the control of the laboratory [13]. ID errors lack a standardized 
definitiona and systems for detecting, reporting, measuring and categorizing them and their 
consequences among laboratories and health care organizations. They are generally 
considered underreported as the true frequency includes undetected errors [8, 11]. As a 
consequence, reported ID error results can vary among organizations due to differences in 
measurement methods and how effective laboratory and clinical staff are in identifying 
errors [8, 9], which makes it difficult to arrive at conclusions about the true size and 
variability of the ID error quality gap.
aSee Glossary for more detailed information on ID errors and associated terms.
Snyder et al. Page 2













Reported ID error rates of 1% and less are common [3, 10, 16–20], yet are still considered a 
serious problem since any error has the potential for serious adverse patient consequences. 
The lowest rates are associated with transfusion medicine and are usually less than 0.1%, 
followed by the general pathology laboratory at closer to 1%, but as high as 10% [21–26], 
with even higher rates found in surgical pathology [8, 13, 27]. While errors rates at or very 
close to 0% have been documented, the upper end of the range could be as high as 50%. The 
highest rates[23, 27] have been measured by a prospective, direct observation method using 
surgical specimen requisitions and container labeling with an extensive list of variables 
included in the ID error definition. Most detected errors do not harm patients since their 
detection results in the associated erroneous test reports typically not being released by the 
laboratory [8, 9, 28].
2.0 Methods
This evidence review followed the “A-6 Cycle” systematic review methods for evaluating 
quality improvement practices funded by the CDC’s Laboratory Medicine Best Practices 
Initiative (LMBP) and reported in detail elsewhere [4]. This approach is derived from 
previously validated methods, and designed to transparently evaluate the results of studies of 
practice effectiveness to support evidence-based best practice recommendations. A review 
team conducts the systematic review and includes a review coordinator and staff trained to 
apply the LMBP methods. Guidance is provided by a multi-disciplinary expert panel 
including at least one LMBP Workgroup member and individuals selected for their diverse 
perspectives as well as relevant expertise in the topic area, laboratory management, and 
evidence review methods.b The results are translated into an evidence-based best practice 
recommendation by the expert panel for approval by the LMBP Workgroup. These methods 
as applied in this evidence review of barcoding practices are presented below.
2.1 ASK: Review question and analytic framework
The LMBP methods begin with the ASK step which frames at least one review question 
supported by an analytic framework and PICO elements (population, intervention/practice, 
comparator, outcome). The question answered by this evidence review is:
Are barcoding practices effective at reducing patient specimen and laboratory 
testing identification errors?—This review question is addressed in the context of an 
analytic framework for the quality issue of patient specimen and laboratory testing 
identification errors (Figure 1). The relevant PICO elements are:
• Population: all patients in healthcare settings using laboratory or point-of-care 
testing and their specimens requiring accurate identification for use in a healthcare 
context
• Intervention: barcoding practices defined as laboratory test barcoding systems 
using barcoded patient identification linked to specimen labels or point-of-care 
testing
bSee Appendix A for the LMBP Patient Specimen Identification Expert Panel Members. LMBP Workgroup members are listed at: 
https://www.futurelabmedicine.org/about/lmbp_workgroup/
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• Comparison practice/intervention: non-barcoded identification systems for patients, 
specimens and laboratory tests
• Outcome: specimen and/or laboratory testing identification error rates are the 
primary and most direct outcome of interest.
The two barcoding practices being evaluated in this review are described below.
Barcoding Systems: Electronic barcoding for identification of patients, specimens and 
laboratory testing is used to positively establish identification and link specimens and tests 
to a patient throughout the entire testing process including test ordering, specimen 
collection, analysis and test result reporting[13]. Barcode scanners are used to confirm 
patient identity. Other options include barcoded patient wristbands, portable printers to 
generate labels at the bedside, and use of an interface with a computerized physician order 
entry (CPOE) system.
Point-of-Care Test Barcoding Systems: Automated patient specimen and laboratory 
testing identification system use bar-coded patient identification and bar code scanners with 
a testing device at or close to the patient. Testing devices can interface with laboratory 
information systems to receive and transmit patient identification and test result information. 
This practice may include barcoded patient wristbands.
2.2 ACQUIRE: Search for practice effectiveness evidence
The search for studies of barcoding practice effectiveness to reduce patient specimen and 
laboratory testing ID errors included a systematic search of multiple electronic databases, 
hand searching of bibliographies from relevant information sources and their bibliographies, 
provision of references by as well as consultation with experts in the field including 
members of the expert panel (Appendix A). Additional evidence was obtained by 
solicitation of unpublished quality improvement studies resulting in submissions to the 
Laboratory Medicine Best Practices Initiative.c The literature search strategy and terms were 
developed with the assistance of a research librarian and included a systematic search in 
August 2011 of three electronic databases (PubMed, Embase and CINAHL) for English 
language articles from 1995 to 2012 about human subjects. The search contained the 
following Medical Subject Headings: automatic data processing, blood transfusion, 
hospitals, laboratories, methods, patient identification systems, patients, and specimen 
handling as well as these keywords: barcode/bar-code/bar code, labeling errors, laboratory/
ies, methods/strategy(ies) reduce patient specimen handling practice/identification errors, 
patient identification systems errors, pharmaceutical, specimen, and transfusion.
2.3 APPRAISE: Screen and evaluate evidence
The ACQUIRE step search results are reviewed by an initial screening of titles and abstracts 
using pre-specified inclusion criteria consistent with the ASK step, followed by a full-text 
review of all eligible effectiveness studies, involving abstracting, standardizing and 
cMore information on submission of unpublished studies to the Laboratory Medicine Best Practices Initiative is available at 
www.futurelabmedicine.org
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evaluating study quality using the LMBP methods. Included studies are considered to 
provide valid and useful information addressing the review question [29] with barcoding 
effectiveness findings that include at least one ID error outcome measure. To reduce 
subjectivity and the potential for bias, all screening, abstraction and evaluation is conducted 
by at least two independent reviewers, and all reviewer discrepancies are resolved through 
consensus. The effect size for each study was standardized using its reported data and results 
to calculate an odds ratio (OR)d since the outcome of interest is dichotomous (i.e., correctly 
identified versus misidentified) and the findings for these practices are typically expressed in 
terms of rates or percentages. The OR compares the barcoding practice to a non-barcoding 
practice in terms of the relative odds of a successful outcome (i.e., the patient’s specimen 
and/or test is correctly identified versus incorrectly identified). Each study is assigned one of 
three quality ratings (Good, Fair, Poor) and one of three effect size ratings (Substantial, 
Moderate or Minimal/none).e
2.4 ANALYZE: Evidence review synthesis and results
The individual effectiveness study results from the APPRAISE step are aggregated into two 
practice-specific bodies of evidence (barcoding systems and POCT barcoding) and then 
analyzed to produce the systematic review practice effectiveness results for translation into 
evidence-based recommendations (Recommend, No recommendation for or against, 
Recommend against). Both qualitative and quantitative analyses are used to assess effect 
size consistency and patterns of results across studies [30]. Qualitative analysis is used to 
rate the overall strength of the body of evidence for practice effectiveness (High, Moderate, 
Suggestive, or Insufficient) Criteria for these ratings are described in detail elsewhere [4, 
31]. The qualitative analysis synthesizes the individual studies to convey key study 
characteristics, results and evaluation findings summarized in a body of evidence table. A 
quantitative analysis is provided using meta-analysis of the results from similar individual 
studies to estimate a weighted average effect size and confidence interval using a random-
effects modelf with the results presented in a forest plot.
3.0 Evidence review synthesis and results
The ACQUIRE step procedures identified 1,307 separate bibliographic records that were 
screened for eligibility to contribute evidence of the relation of barcoding with ID error 
outcomes. The APPRAISE step screening resulted in 1,211 of these records being excluded 
as off-topic, and 73 being excluded for not meeting effectiveness study inclusion criteria 
(i.e., not a study, no barcoding practice, no ID error outcome measure) for a total of 23 full-
text studies meeting the review inclusion criteria. A systematic review flow diagram in 
Figure 2 provides a breakdown of the search results. Abstracted and standardized 
information as well as study quality ratings for the 23 eligible studies are provided in 
Appendix B containing evidence summary tables preceded by a Body of Evidence table for 
dSee Glossary for more information on odds ratios.
eThe criteria for a Substantial effect size rating: OR > 2.0 and significantly different from OR =1.0 at p = 0.05 (i.e., the lower limit of 
the 95 percent confidence interval is > 1.0).
fRandom-effects model assumes there is no common population effect size for the included studies and the studies’ effect size 
variation follows a distribution with the studies representing a random sample. This is in contrast to the fixed-effects model which 
assumes a single population effect size for all studies and that observed differences reflect random variation.
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each practice. Bibliographic reference information for these studies is provided in Appendix 
C.
The full-text review and evaluation of the 23 eligible studies resulted in the exclusion of 6 
studies due to “poor” study quality ratings which did not meet the minimum required LMBP 
study quality inclusion criteria (4 barcoding systems studies: 3 published and 1 unpublished; 
2 point-of-care test barcoding studies: 1 published and 1unpublished). A total of 17 studies 
are included in this review as evidence of practice effectiveness (8 of which are unpublished 
submissions): 10 studies for barcoding systems (3 unpublished) and 7 studies for point-of-
care test barcoding (5 unpublished). All included studies used observational before-after 
study designs.
3.1 Barcoding systems practice effectiveness evidence
Of the 10 studies included in the barcoding systems practice body of evidence, 7 were 
published and 3 were unpublished, and 6 were rated “Good” study quality and 4 were rated 
“Fair” with summarized information provided in Table 1. The earliest study time period was 
1999–2000, and the starting date for 6 of the studies was 2005 or later, with 3 published in 
2010. All study sample sizes were very large while the number of identification errors was 
very small. In all studies both the barcoding and the non-barcoding comparison groups were 
considerably in excess of 1,000 specimens. All but 2 studies exceeded 10,000 specimens for 
both groups, and 3 studies exceeded 100,000 specimens. All 10 included studies involved 
laboratory testing with identification of patient specimens using labels in U.S. hospital 
settings; 8 studies from clinical pathology laboratories and 2 from surgical/anatomic 
pathology laboratories (Zarbo 2009 and University of Washington 2009). There was 
geographic and patient diversity across study settings which included inpatient, outpatient, 
emergency department and pediatric settings. All hospitals were relatively large, with the 
smallest exceeding 200 beds. Four studies relied exclusively on inpatient blood specimens 
and used bedside label printing (Brown 2010, Morrison 2010, LBJ 2009, Unpub A 2009), 
and two studies relied only on emergency department specimens (Hill 2010, Killeen 2005).
3.1.1 Body of evidence qualitative analysis—As summarized in Table 1, the 
evidence of practice effectiveness for reducing ID errors indicates consistent improvement 
associated with barcoding systems compared to non-barcoding practices with a high strength 
of evidence in hospital settings. The odds ratio for 9 of the 10 barcoding system studies 
exceeded 2.0 (favoring barcoding), and the 95% confidence interval lower limit exceeded 
1.0 for 8 of the 10 studies. The 3 study exceptions (Bologna 2002, Morrison 2010, and LBJ 
2009) had the smallest numbers of ID errors in the barcoding and non-barcoding study 
groups ranging from 0 to 12 which corresponded to very large sample sizes; the smallest 
being about 25,000 and the rest substantially larger. The odds ratio estimates for all 10 
included studies ranged from 1.7 to 147. The unpublished studies’ odds ratios were 
consistent with those of the published studies with the exception of the uppermost 
unpublished study odds ratio of 147.
3.1.2 Meta-analysis—The forest plot in Figure 3 presents the meta-analysis effect size 
results for barcoding systems. The odds ratio for each of the 9 included studies favors the 
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barcoding system practice over the non-barcoding practice for improving identification error 
rates indicating a consistent and statistically significant effect. The overall summary effect 
mean odds ratio was 4.39 (95% CI: 3.05 – 6.32). The higher rated “Good” study quality 
subgroup summary effect size exceeded that of the lower rated “Fair” quality subgroup with 
an odds ratio of 5.14 versus 2.43. The lower limit of the confidence interval for both 
subgroups exceeded 1.0 at 3.41 for the 6 “Good” quality studies but only 1.1 for the 3 “Fair” 
studies. One of the ten barcoding system practice effectiveness studies was excluded from 
the meta-analysis (University of Washington 2009) as its ID error rate outcome measure 
(processed specimen cassettes/blocks rather than specimens in their original containers with 
labels) and results (OR = 147; 95% CI: 55 – 391) were considered too heterogeneous 
relative to the other nine included studies.
Meta-analysis results for barcoding systems show significant statistical heterogeneity which 
is typical of random effects results. The I2 statistic ranges from 0–100% and estimates the 
percent of variability in estimates attributable to between study differences. Studies rated 
“Good” showed somewhat less between-study variation (10.5%) relative to “Fair” studies 
(15.9%) which had larger estimated odds ratios. This modest attenuation of effect size from 
“Fair” studies contributes to modest between-study variation (24.8%) in the overall estimate.
3.2. Point-of-care test barcoding practice effectiveness evidence
Of the 7 studies included in the point-of-care barcoding practice effectiveness body of 
evidence, 2 were published and 5 were unpublished, and 5 were rated “Good” study quality 
and 2 were rated “Fair” with summarized information provided in Table 2. All of the 
included studies relied on U.S. hospital inpatient point-of-care glucose tests, with at least 4 
studies also including emergency department patient tests. The earliest study time period 
began at the end of 2002, while the remaining studies began in 2006 or later, with 4 ending 
in 2011. Like the barcoding systems’ practice effectiveness studies, the point-of-care test 
barcoding study sample sizes were typically very large with all barcoding and non-
barcoding groups exceeding 10,000 tests with one exception (Rao 2005). Several studies had 
barcoding and/or comparison groups with substantially more than 100,000 tests. Four of the 
unpublished studies came from separate hospitals within one hospital system (Catholic 
Health System: Kenmore Mercy Hospital, Mercy Hospital of Buffalo, Sisters of Charity 
Hospital Buffalo and Sisters of Charity Hospital St. Joseph Campus). As a result, the body 
of evidence is not as geographically diverse as for barcoding systems, but the study settings 
may be reasonably representative of diverse hospitalized patient populations.
3.2.1 Body of evidence qualitative analysis—As summarized in Table 2, the 
evidence of practice effectiveness for reducing identification errors indicates consistent and 
substantial improvement for point-of-care test barcoding compared to non-barcoding 
(manual entry) practices with a high strength of evidence for point-of-care glucose testing in 
hospital settings. The point-of-care barcoding practice odds ratio for all 7 of the included 
studies exceeded 2.0 (favoring the barcoding practice over non-barcoding practices), and the 
lower limit of the odds ratios’ 95% confidence interval exceeded 1.0 for 6 of the 7 studies. 
The one study exception (Rao 2005) had the smallest numbers of errors (4 without 
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barcoding; 0 with barcoding) and the smallest total sample size (462) of the included studies. 
The odds ratio estimates for all the included studies ranged from 3.76 to 14.72.
3.1.2 Meta-analysis—The forest plot in Figure 4 presents the meta-analysis results for the 
point-of-care test barcoding practice. The overall summary effect mean odds ratio was 5.93 
(95% CI: 5.28 – 6.67). The 5 higher rated “Good” quality studies’ subgroup summary effect 
size was similar: mean odds ratio of 5.83 (95% CI: 3.86 – 8.82). Of the 7 included studies, 
only one had an odds ratio 95% confidence interval lower limit less than 1.0 (Rao 2005), 
reflecting the very small number of identification errors in the study (4) as well as a 
relatively small sample size (462). These meta-analysis results show significant statistical 
heterogeneity as is typical of random effects results. Most of the point-of-care test barcoding 
meta-analysis results’ statistical heterogeneity is attributable to within-study variance. The 
higher rated “Good” study quality subgroup showed modest between-study variation (I2 = 
27.8%) while all between-study variation in the fair and overall results can be attributed to 
chance. At the aggregate level, results for “Fair” and “Good” studies are essentially 
indistinguishable and can be considered well represented by the overall mean estimate.
4.0 Discussion
4.1 Additional considerations
4.1.1 Applicability—Barcoding practices demonstrated effectiveness at reducing ID errors 
for patient specimen and laboratory testing identification is generalizable to most common 
hospital settings and patient populations, to clinical pathology laboratory testing, and 
potentially to surgical/anatomic pathology laboratory testing for which there was more 
limited evidence [28, 32, 33]. Although barcoding effectiveness studies for non-hospital 
settings and point-of-care testing other than glucose were not included in the body of 
evidence reviewed, barcoding may be similarly effective at reducing ID errors but no 
evidence was available to test this hypothesis. Cost, technological requirements and training 
may be barriers to adoption of barcoding in some non-hospital settings, as well as hospital 
settings, however this is not clearly supported. In relatively low volume testing settings, 
limited economies of scale for barcoding technology may present a cost barrier. Non-
hospital settings generally do not rely on patient identification armbands typically used in 
hospital inpatient and emergency departments, but patients may have specimen container or 
test requisition form labels with identification information that can be barcoded.
4.1.2 Harms—Barcoding technology is not error free. ID errors associated with barcoding 
practices include those created by the patient identification barcodes themselves [34]. 
Barcode scanners may misread patient identification barcodes due to incompatibility 
between the barcode print area size or symbology on patient ID bands or specimen labels 
with scanner settings. In one study a small number of scanner misreads occurred due to the 
narrow wrist band curvature of pediatric patients [35]. Other sources of barcoding ID errors 
included labels being unreadable by a scanner due to label print quality problems, which 
may indicate a need for label printer maintenance, and degradation of the barcode on the 
patient ID band from being worn or written on. Studies and articles have also reported 
scanner failure attributable to low batteries [36]. Even when the scanner works properly, 
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incorrect information such as the wrong patient’s barcode, incorrect barcode information 
from a patient’s ID band, or non-patient identification barcodes (e.g., medication) can cause 
ID errors [37, 38]. A specific type of ID error is from scanning incorrect barcode 
information from a patient ID band with a barcode related to a previous hospitalization or a 
hospital transfer. Such an episode could include more than one armband and/or multiple 
patient accounts [37, 39]. Although many potential sources of ID errors associated with 
barcoding have been identified, these errors appear relatively rare, generally preventable, 
and likely have only a negligible impact on ID error rates.
4.1.3 Additional benefits—The studies reviewed report other beneficial outcomes 
associated with barcoding including an observed reduction in misidentified patients [40], 
unnecessary phlebotomy [40], labor time savings and reduced workflow process time in 
surgical pathology [32, 33]. Implementing barcoding has been credited with improving 
identification of those responsible for making ID errors, thus enabling targeted measures to 
improve performance [37, 40]. Cost savings noted from fewer ID errors associated with 
barcoding include reductions in specimen recollections, labor to investigate and correct ID 
errors, length of patient stays and legal issues [41]. Additional benefits to patients from 
fewer ID errors include avoiding unnecessary discomfort, inconvenience, and treatment 
delays from recollecting and retesting specimens [40, 42].
4.1.4 Economic evaluation—No patient specimen barcoding practice economic 
evaluations (cost, cost-effectiveness, or cost-benefit analyses) were found in the search 
results described in section 2.2.g Completing a resource-related inventory for barcoding 
practices is beyond the scope of this study but it should include the costs associated with 
implementing and sustaining the practice (e.g., hardware, software, equipment, supplies and 
labor requirements as well as resources associated with training, testing, monitoring, and 
maintenance) and all downstream costs and savings that occur because the intervention was 
performed [43].
4.1.5 Feasibility of implementation—The evidence reviewed clearly demonstrates the 
feasibility of adopting barcoding practices in a variety of hospital settings. Nevertheless, 
each environment is distinctive and implementation requires adequate process development 
and modification, training, education and testing to achieve full effectiveness. Barcoding 
process design issues appear more complex for surgical pathology [32, 44] which typically 
involves more workflow process steps than patient specimens for routine laboratory or 
point-of-care testing. Many studies on surgical pathology describe the approach used for 
barcoding-related process changes in detail, along with the accompanying challenges and 
solutions [32, 36–38, 40, 42, 45]. Key implementation components for making barcoding 
technology work as intended include adequate training and education, well-designed patient 
ID bands, and adequate supplies and equipment maintained in good working order (e.g., 
label printers, computers, batteries, wireless networks) [13]. Shortages and performance 
gSimilarly, additional searches covering the following databases completed in September 2011 identified no economic evaluations: 
EconLit, Cost Effectiveness Analysis (CEA) Registry, and the U.K. National Health Service (NHS) National Institute for Health 
Research Centre for Reviews and Dissemination (CRD) Economic Evaluation Database (EED) and Health Technology Assessment 
(HTA) Database.
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issues were noted as problems frustrating staff that can result in using error-prone work 
around processes [42]. Support and involvement from all relevant departments and leaders 
including nursing, laboratory and information systems, were identified as critical success 
factors since no one department typically has full ownership of implementing and using 
barcoding technology.
4.2 Future research needs
Standardized outcome measures and measurement methods that consistently and reliably 
detect ID errors are needed for robust evaluation and comparison of QI practices. For more 
complete and useful assessment of barcoding practices, studies are needed to address its 
applicability and effectiveness in ambulatory and non-hospital settings, as well as more 
research evaluating barcoding in surgical pathology and settings known to have relatively 
higher ID error rates (e.g., emergency departments). Cost-effectiveness studies evaluating 
investments in potentially expensive ID error reduction technologies such as barcoding are 
needed. There should be a focus on settings with greater potential ID error impact due to 
higher rates and/or more serious consequences. Addressing this requires well-constructed 
data collection and analysis efforts identifying and measuring resources needed for 
implementation and maintenance of barcoding along with outcomes of interest. Future 
effectiveness research can be more informative if expected barcoding effectiveness 
moderators including implementation variables or practice components (e.g., electronic 
order system interface, bedside labeling, different barcode formats) can be evaluated for 
their contribution to overall effectiveness. Other benefits and harms of barcoding for patient 
specimen identification have not been well studied or reported and may be unknown. More 
information on other potential practice effects is needed to evaluate the full range of 
consequences and to allow for a comprehensive assessment of its net benefit. In addition, 
more information is needed about how to maintain and enhance the effectiveness of 
barcoding over time.
4.3 Limitations
The LMBP systematic review methods are consistent with practice standards for systematic 
reviews[30], but all such methods are imperfect and include subjective assessments at 
multiple points that may produce bias. Like most systematic reviews, this one may be 
subject to publication bias, although this review includes unpublished studies which may 
mitigate that bias. The restriction to English language studies to satisfy the requirement of 
multiple reviewers for each study may also introduce bias if barcoding practices differ 
substantially in international settings. Quality improvement efforts typically differ from 
research, and are commonly observational studies that rely on natural experiments in 
realistic practice settings. The major drawback of these uncontrolled designs is that it is not 
possible to know if measured or unmeasured factors affect the outcomes of interest. 
Regardless of study design, by gathering evidence from multiple clinical and organizational 
settings, systematic reviews provide more useful assessments of the totality of evidence for a 
given QI practice than individual studies [46].
Barcoding and other technology or practice changes may be easier to measure than 
individual step process changes that may contribute to observed results. Also, these 
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processes are rarely uniform, and are clearly very different for clinical versus surgical 
pathology specimens, and for point-of-care testing. While these factors may moderate study 
findings and the observed heterogeneity suggests they are not insignificant, it can be 
observed that all studies reported support for barcoding.
Some studies comprising the barcoding body of evidence involved less than full 
implementation for all or a portion of the post-implementation period which would have an 
expected tendency to understate the impact of barcoding on the reduction in ID error rates. 
In particular, some studies indicated barcoding “scan rates” of substantially less than 100 
percent during the post-implementation period such that the effect of a non-barcoding 
practice (i.e., manual entry of patient identification information) is reflected in a portion of 
the post-implementation data. This was noted when provided, however as it was not always 
clearly or consistently reported it could not be used to adjust effect size estimates. As studies 
were done within a single institution, there may be many site-specific differences that 
impact their study results. Many studies were missing information including actual study 
sample sizes, dates for relevant time periods, and practice implementation and setting 
characteristics. Another perceived limitation is the inclusion of unpublished studies.
Designing and publishing controlled studies are typically not among the primary objectives 
of individuals collecting and analyzing quality improvement data relevant to laboratory 
medicine. In the barcoding body of evidence, both the published and unpublished studies 
had similar limitations. The LMBP experience to date in reviewing and rating study quality 
for both published and unpublished studies indicates that peer-reviewed journals do not 
provide assurance of high study quality.
5.0 Conclusion and Recommendation
On the basis of a high overall strength of evidence of effectiveness, barcoding systems for 
specimen labeling and point-of-care test barcoding are recommended as best practices to 
reduce identification errors and improve the accuracy of patient specimen and laboratory 
testing identification in hospital settings. The high overall strength of evidence is due to 
sufficient evidence of practice effectiveness from individual studies demonstrating 
consistent and substantial reduction in patient specimen and laboratory testing-related 
identification error rates in hospital settings. The findings of barcoding effectiveness are 
based on 10 studies of specimen barcoding systems and 7 studies of point-of-care test 
barcoding assessing impact on identification errors. In every study barcoding is associated 
with a reduction in the identification error rate. The meta-analysis overall summary effect 
mean odds ratio favoring barcoding is 4.39 (95% confidence interval: 3.05 – 6.32) for 
barcoding systems and 5.93 (95% confidence interval: 5.28 – 6.67) for point-of-care test 
barcoding. There was limited evidence of additional benefits and potential harms associated 
with the use of barcoding for specimen and laboratory testing identification, and any effect 
of potential harms appears to be very small relative to its overall benefits. All included 
studies were conducted in hospital settings. No evidence was available for assessing the 
effectiveness and applicability of barcoding in other laboratory testing settings.
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Melissa Gustafson of Battelle, Devery Howerton, Malaika Washington, and Barbara Zehnbauer of the Centers for 
Disease Control and Prevention, the LMBP Patient Specimen Identification Expert Panel and LMBP Workgroup 
members, and Submitters of unpublished studies
ABBREVIATIONS
CDC U.S. Centers for Disease Control and Prevention
CI Confidence interval
ID Identification
IOM Institute of Medicine
LMBP Laboratory Medicine Best Practices Initiative
QI Quality improvement
GLOSSARY
Bias systematic error; threats to validity; tendency to produce results that 
depart systematically from the ‘true’ results. Unbiased results are 
internally valid. Four types of bias are selection/allocation, 
performance, measurement/detection and attrition/exclusion.
Consistency The degree to which estimates of effect for specific outcomes are 
similar across included studies.
External 
validity
Generalizability, applicability – extent to which the effects observed in 
the study are applicable outside of the study to other populations and 
settings.
Effect size A value which reflects the magnitude of the difference in a study’s 
outcome measure between the group with the intervention/practice 
being evaluated and its control or comparison group.
ID errors Misidentification in matching a patient or a specimen with a laboratory 
test. ID errors may include specimen/test requisition mismatches (e.g., 
specimen labeled with another patient’s name, wrong type of 
specimen, duplicate orders or specimens), mislabeled specimens 
(sometimes referred to as “wrong blood in tube”), specimen label with 
partial, missing or incorrect information (e.g., one of two patient 
identifiers, missing or wrong patient gender, date of birth or middle 
initial), and unlabeled specimens.[9, 12] Different institutions may use 
different denominators when expressing ID errors as a rate (e.g., 
number of specimens, phlebotomies, requisitions, accessions). Some 
ID error types are more likely to be detected by the laboratory than 
others (e.g., mismatch versus wrong blood in tube), with those detected 
typically preventing the release of a test result.[8] Most ID errors are 
the result of human error, and causes include but are not limited to: 
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laboratory tests ordered on the wrong patient, incorrect or incomplete 
entry of patient data in the laboratory information system, collection of 
specimens from the wrong patient, inappropriate labeling of 
specimens, multiple users of the same label printer, lost identification 
label on specimens, incorrect identification information on specimen 
labels, pre-printed labels from different patients, handwritten labels on 
specimen containers, tissue cassettes and slides, and incorrect entry of 
patient results in the laboratory information system.[13]
Internal 
validity
extent to which the design and conduct of the study are likely to 
prevent systematic error. Internal validity is a prerequisite for external 
validity.
Meta-analysis The process of using statistical methods to combine quantitatively the 
results of similar studies in an attempt to allow inferences to be made 
from the sample of studies and be applied to the population of interest.
Odds ratio The ratio of two odds of an event from two groups - a treatment or 
intervention group (a/c) versus a control group (b/d) where a and c 
represent the number of times the event occurs for the intervention and 
control group, respectively, using the formula below and the barcoding 
and comparison practice example table. An OR =1 means the two 
practices are equally successful (no difference in reducing risk with 
respect to the outcome evaluated); OR >1 means the barcoding practice 
is more successful; and OR < 1 means the barcoding practice is less 
successful. ;
Where pa = a/(a + b), pc = c/(c + d) and a, b, c, and d are proportions 
in the table below.
Frequencies Proportions
Success Failure Success Failure
Barcoding Practice a b pa = a/(a + b) pb = b/(a + b)
Comparison Practice c d pc = c/(c + d) pd = d/(c + d)
Systematic 
review
A scientific investigation that focuses on a specific question and that 
uses explicit, planned scientific methods to identify, select, assess, and 
summarize the findings of similar but separate studies. It may or may 
not include a quantitative synthesis of the results from separate studies 
(meta-analysis).
Transparency Methods are explicitly defined, consistently applied, and available for 
public review so that observers can readily link judgments, decisions, 
or actions to the data on which they are based. Allows users to assess 
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the strengths and weaknesses of the systematic review and associated 
guidance and recommendations.
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APPENDIX B. Laboratory Medicine Best Practices Body of Evidence Table










EvidenceStudy Practice Measures Results Total Rating
Published
Bologna 2002 3 2 1 1 7 Fair Moderate 5 Studies 
= Good/
Substantial
Brown 2010 2 2 2 3 9 Good Substantial
Fabretti 2011 2 2 0 1 5 Poor N/A
Hayden. 2008 3 2 1 2 8 Good Substantial 2 Studies 
= Fair/
Substantial
Hill 2010 2 2 2 3 9 Good Substantial
Killeen 2005 3 2 1 3 9 Good Substantial 1 Study = 
Good/
Moderate
Morrison 2010 2 2 2 1 7 Fair Moderate
Sandler 2005 0 1 1 0 2 Poor N/A 2 Studies 
= Fair/
Moderate
Turner 2003 1 1 1 1 4 Poor N/A
Zarbo 2009 2 2 2 3 9 Good Substantial 4 Studies 
= Poor - 
Excluded
Unpublished
LBJ 2009 2 2 2 2 8 Good Moderate
U of MN 2009 1 2 2 0 5 Poor N/A
U of WA* 2 2 2 1 7 Fair Substantial
Unpub A 2009 1 2 1 2 6 Fair Substantial
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printer; labels printed 
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- Duration: 9 months 
(1/2000 – 9/2000); 
ongoing
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- The Valley 
Hospital, 
Ridgewood NJ
- Funding: not 
reported
- Time period: 
1/1999 – 9/2000
Pre: 1 year (1/1999–
12/1999)









Combination of print 
and hand-written 
labels used
- Study bias: None 
noted








printers, BD System 
Software; bar-coded 
wristbands
























































Study (3 pts 
maximum): 3
Practice (2 pts 
maximum): 2
Outcome measures 
(2 pts. maximum): 
1; Recording 
method: Not 
reported for pre 
period
Results/findings (3 
pts maximum): 1; 
Appropriateness of 
statistical analysis: 
Pre and Post 
estimates appear to 
rely on different 
recording methods
- Brown JE [1], 
Smith N [1], 
Sherfy B. [2]
- 2010






of Johns Hopkins 
Medicine















bed, nonprofit acute 
care community 
hospital – 6 inpatient 




- Time Period: 
11/2005 – 10/2007
Pre: 1 yr. (11/2005 – 
10/2006)
Post: 1 yr. (11/2006–
10/2007)
- Sample: Inpatient 







with hospital, lab and 
physician order entry 
information systems 
for printing barcoded 
specimen labels at the 
bedside using a 
portable label printer 
generated from 
laboratory orders 
entered from an order 
management system
-Duration: 12 mos. - 
Implemented 11/2006 
in limited number of 
units; subsequently 
expanded hospital-




errors/rate (# and 
%): Wrong patient 
name or specimens 
with multiple patient 



































published article for 
error rates as 
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with patient care 
technicians (PCTs) 
and RNs printing 
specimen labels at 
nurse’s station central 
printer; implemented 
methods and 
education to decrease 
errors.
- Study bias: 
Barcoding 
implemented in one 
unit and after one 
month the other 5 
units in post period 
one noted
-Training: 1 hour 
staff training, one 







Staff: Patient care 
technicians (PCTs) 




handheld or beside 









event reports for 
specimen labeling 
errors entered by 










Whitney U Test 
showed a significant 
difference in the 
mean number of 














Study (3 pts 
maximum): 2; 
Potential study bias - 
Barcoding 
implemented in one 
unit and then after 
one month the other 5 
units in post period
Practice (2 pts 
maximum): 2
Outcome measures 

















Pathology Lab.; no 
additional 
information reported
- Time period: 2009 









- Study bias: None 
noted
-Description: 
Database and lab 
information system 
integrated using HL7 
messages for patient 
ID data to be acquired 
from hospital records 
and transferred to 
local database. 
Examination phase: 
ID code obtained 
using barcode reader 
and automatically 
printed on cassette. 
Cutting phase: ID 








Given in classrooms 
equipped with PCs to 
medical and 
paramedical staff who 
work in OR; other 
staff followed.
- Staff/Other 
resources: 8 doctors, 
4 biologists, 14 
biomedical 
technicians, 2 admin 
- Description: Error 
Rates
(1) Misinterpretation 
of handwritten data 
on request forms 
and sample labels









Post: Request and 
labels data recorded 
twice (printed by 
machine and on 
barcode). System 
identifies patient 
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assistants. IT Dept, 
Pathology Lab, 
medical, nursing and 
administrative staff of 
various hospitals in 
Rimini. Two 
databases and lab 
information system.
- Cost: Not reported
Quality Rating: 









Study (3 pts 
maximum): 2
- Study Setting: 
Sufficiently 
distinctive that results 
may not be 
generalizable to other 
settings/specimens – 
Surg. path. specimen 
cassettes
Practice (2 pts 
maximum): 2
Outcome measures 
(2 pts. maximum): 
0; Face Validity -
Outcome measure 
confounded by 
practice itself (no 
comparison)
Results/findings (3 
pts maximum;: 1; 
Appropriateness of 
statistical Analysis- 
Insufficient data to 
allow/verify 




Patterson DJ, Jay 
DW, Cross C, 
Dotson P, Possel 
RE, Srivastava 
DK, Mirro J, and 
Shenep JL.
- 2008
- Journal of 
Pediatrics







- Funding: Partly 
self- financed; 







- Facility/Setting: St. 
Jude Children’s 
Research Hospital, 
Memphis, TN ; 
pediatric cancer 
center
- Time period: 
9/2003 – 8/2006; 36 
months









of all tissue and body 
fluid specimens (test 
ordering events) 
approximating 




downtime, off site 
and by cardiac arrest 
team.
Pre: 19,247 mean 
accessions per month 
(1 year)
Post: 17,793 mean 
accessions per month 
(1 year)
- Comparator: Not 
reported





(EPPID) system with 
barcoding. Handheld 
personal digital 
assistants in each 
patient, clinic and 
procedure room with 
scanner to track and 
verify clinician 
entered orders at point 
of collection; labels 
printed centrally at 
nursing station.




- Training: 3-week 




user training on 
routine hardware and 




on training for new 





collections by nursing 
staff)
- Cost: Not reported
- Description: 
Mislabeled 
specimens (# and % 
of total accessions): 
mismatches between 
patient name and. 
specimen (wrong 




Methods: QA data 
collected (method 
not specified) based 
on telephone 
notifications: 1) 
nursing alerting lab 
of labeling error; 2) 
test results for 
patients no longer 
in- house; 3) 
inquiries to lab 
about patient results 
from whom no 



















Test(s): p < .001





8 (Good) (10 
point maximum)
Study (3 pts 
maximum): 3;
Practice (2 pts 
maximum): 2
Outcome measures 
(2 pts maximum): 
Results/findings (3 
pts maximum): 2; 
Appropriateness of 
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specified; may differ 
for practices
Hill PM [1,2], 
Mareniss D [1,2], 
Murphy P [2], 
Gardner H [2], 
Hsieh Y [1], Levy 
F [1,2], Kelen GD 
[1,2]
- 2010
- Annals of 
Emergency 
Medicine



















department (ED) with 
annual census of 
57,000
- Time Period: 
9/2004 – 9/2009
Pre: 44 mos. (9/2004 
– 4/2008)
Post: 17 mos. (5/2008 
– 9/2009)
- Sample: All 
specimens collected 







ordering and labeling 
process; nurse stamps 
blank labels using 
embosser with plastic 
patient id card




(not barcoded); some 
from work-arounds, 
but may include 
errors that should be 
excluded (blood 
bank, tissue, Level 1 








integrated with the 
LIS including 
physician order entry 
combined with bar-
code technology 
linked to patient’s 
identity; physician 
order entry generates 
printed barcode 
specimen labels near 
patient’s room. Not 
used for blood bank, 
tissue, Level I trauma 
and severe critical 
care specimens
- Duration: 17 
months (5/2008- 
9/2009); ongoing










integrated with a 
laboratory 
information system 
and physician order 
entry system, patient 
wristbands containing 





- Cost: Not reported
- Description: 
Specimen 
processing error rate 














records. Data from 










































Study (3 pts 
maximum): 2 
Potential study bias - 
Errors and specimens 
from non- barcoded 
specimens not 
explicitly excluded
Practice (2 pts 
maximum): 2
Outcome measures 
(2 pts maximum): 2
Results/findings (3 
pts maximum): 3
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– Time Period: Two 
6-month periods (Pre 
and Post); dates not 
reported
- Sample: All 
Emergency 
Department (ED) 
patients seen during 
study period (annual 
census: 40,000) with 
ancillary ED 
laboratory tests





Imprint stamp sticker 
labels on specimens 
and paper requisitions
-Study limitation: 











physician order entry 
(CPOE). Label 
printing location not 
specified.
- Duration: 6 months 







- Cost: not reported
- Description: PSID 














Size: PSID Error rate
Pre : 2.56 per 1,000 
[CI: 1.94–3.32] 
(0.26% = 57/22,243)
Post: 0.49 per 1,000 
[CI: 0.24–0.87] 






















Study (3 pts 
maximum): 3
Practice (2 pts 
maximum): 2
Outcome measures 






- Morrison AP 
[1,2], Tanasijevic 
MJ [2], Goonan 
EM [2], Lobo 
MM [2], Bates 
MM[1], Lipsitz 


















Boston, MA, a 777-
bed academic medical 
center
- Time period: 
10/2007 – 6/2009
Pre: 10 mos. 
(10/2007 – 7/2008)
Post: 10 mos. (9/2008 
– 6/2009)












printers and integrated 




Specimens labeled at 
bedside (no preprinted 
labels). No CPOE.
- Duration: 18 mos. 












Pre: Lab staff 
compared patient 
identifiers on 
specimen label and 
requisition form at 
receipt. Recorded as 
mislabeled if 
identifiers did not 
match or later 
-Pretest-Posttest
- Findings/effect 
size: Overall labeling 
error rate per 10,000
Pre: 5.45 (95% CI: 
4.47 – 6.63)










Pre: 0.030% (55 
errors)
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neonatal ICUs and 





Manually pre- printed 
patient addressograph 




- Study Bias: Only 
phlebotomist 





higher error rates. 
Post-implementation 
less than 100% 
barcoding (reported 
85% in 8th month).
- Training: 1.5 hour 
group introductory 
sessions followed by 
individual training of 
each phlebotomist 
accompanied by an 








purchased for a team 
of 39 inpatient 
phlebotomists 
covering 3 daily shifts
- Cost: Not reported
determined sample 
from a different 
patient; without 
labels recorded as 
unlabeled.
Post: Audit data 
collected by 





collection; created a 
mismatch alert 
preventing a wrong- 
patient sample draw.




Pre: 0.024% (44 
errors)
Post: 0.015% (27 
errors)
- Stat. Significance 
Test: Logistic 
regression used to 
model rates over 




estimates; before and 
after changes tested 














Study (3 pts 
maximum): 2 
Potential study bias – 
phlebotomists only 
and <100% barcoding 
may understate effect 
size.
Practice (2 pts 
maximum): 2
Outcome measures 
(2 pts maximum): 
2;
Results/findings (3 
pts max.): 1; 
Appropriateness of 
statistical analysis - 
Different recording 
methods pre and 
post; effect size 
estimate modeled
Sandler SG, 
























profit, acute care 
teaching/research 
facility.





- Time Period: 
10/02- no end date 
provided
- Sample: >125 tests, 
all blood samples and 




- Study bias: No 
time period and 
number of patients 
represented by 
transfusions reported. 
Focus on nurses who 
- Description: 
Barcoding system for 
transfusion linking 
patients’ wristbands 
with blood component 
labels. Consists of the 
hand-held PC/bar-
code scanner with 
radio frequency port 
to a portable printer.
Duration: 10/02 - ?
(no end date)
- Training: provided 
during 1- hour session 
including written and 
instruction review on 
how to use the 
system.
- Staff: Nurses











(2) Number of 
correctly labeled 
samples - labels for 
blood sample tubes 
& certification 










(1) “All (100%) 
patients, blood 






(2) “All (100%) bar-
code-labeled blood 
sample tubes and 
certification forms 







Purpose to focus on 
nurses who transfuse 
blood infrequently, 
yet no data presented 
for these results 
(suggest that these 
nurses perform more 
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Study (3 pts 
maximum): 0;
- Study Setting: 
Sufficiently 
distinctive that results 
unlikely generalizable 
- Bone marrow 
transplant unit 
transfusions (−2)
- Potential Study 
Bias: Study time 
period and sample 
selection may 
introduce bias 
affecting results - 
Study time period not 
reported (−1)
Practice (2 pts 
maximum): 1;
- Adequacy of 
practice description: 
Important aspect 
likely to critically 
affect implementation 
of the practice is not 




(2 pts maximum): 
1; Recording 





- Sample size: 
Measurement period 
not reported; sample 
size likely too small 
for a robust estimate 
of practice impact.
- Appropriateness of 
statistical analysis: 
Data insufficient to 






- Yr Published: 
2003
- Transfusion












Hospital, 1500 bed 
teaching hospital, 
Oxford, UK; Setting: 
Hematology 




- Time Period: Not 
reported
- Sample: First unit 
RBC transfusions:
Pre: 51 (48 blood 
prescribed)
Post: 51. (45 blood 
prescribed)
Sample collection:






process of 27 steps; 
sample collection 
process 17 steps); 
manual checking/
verification of patient 
wristband and chart 
information
- Barcoding system 




wristbands and labels 
via portable printer 
for crossmatch with 
blood administration 
process (16 steps) and 
sample collection and 
verification process (8 
steps) at bedside.




transfusion safety and 
use of the barcode 




bank receptionists, IT, 
blood bank (Note: 
Staff preferred the 
new technology once 
familiar with it)
- Cost: Initial 
equipment/support ~ 






of blood pack 
bedside checks
(1) Patient ID 
(name, DOB, sex, 
hospital #).
(2) Cross ref. of 







collection: % tubes 
labeled immediately 








(1) Blood admin. 
patient ID check: 
Pre: 100% (51 /51)
Post: 100% (51 /51)
0% improvement
(2) Blood admin. 
cross reference 
check: Pre: 9.8% 
( 5/51)
Post: 41.2% (21 /51)
30.4% improvement
p-value : 0.0005
(3) Sample collection 





















Study (3 pts 
maximum): 1;
- Study Setting: 
Sufficiently 
distinctive that results 
may not be 
generalizable – 
Practice (2 pts 
maximum): 1;
- Adequacy of 
practice description: 
Important aspect 
likely to critically 
affect implementation 
Outcome measures 
(2 pts maximum): 
1;
- Face validity: 
Process outcomes 
lack correspondence 
to evidence review 
Results/findings (3 
pts maximum): 1;
- Sample size: 
Measurement period 
not reported; sample 
size likely too small 
for robust estimate.
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- Potential study bias: 
Time period and 
sample selection
of the practice is not 
well described - No 
practice duration 
specified






practice - training 
may have an impact
Zarbo RJ, Tuthill 
JM, D’Angelo R, 
Varney R, Mahar 
B, Neuman C, 
Ormsby A.
- 2009
- Am J Clin 
Pathol








- Facility: Henry 
Ford Hospital, 
Detroit, MI; anatomic 
pathology volumes 
over 80,000 surgical 
pathology lab cases/
year.
- Study Setting: 
Surgical Pathology 
lab gross room
- Time Period: Two 







Specimen parts: Pre: 
4,413; Post: 4,725
Tissue cassettes: Pre: 
8,776; Post: 9,167








by manual entry of 
information and hand 
written labels on 
specimen cassettes 
and slides
- Barcoding system 
and process redesign 
to standardize 
workflow using a 
complex- logic, bar-
coded pathway tying 
together 4 work cells 
to provide computer-
readable encoding for 
identification of parts, 






quality control checks 
at each station (2007 
implementation). No 
electronic order entry 
or interface.
- Duration: 3 weeks - 
July 2007
Training: - Group 
education session, 
ensuring all staff 
mem- bers were in 
unison on the goals 
and time frame of the 
data collection and 
how to use the visual 
data display
- Staff: Surgical 
pathology, histology 
and informatics staff











(3) tissue cassettes – 
mismatch between 
cassette ID and lab 
tag information






categorized by 59 
surgical pathology 
personnel ( 21 
senior staff and 38 
technical staff), 































Post : 0.055% 
(5/9,167)
3.5% reduction; not 
stat. significant









Test(s): χ2 tests 
(Fisher exact test 
adjusted for small 
counts and Mantel- 
Haenszel test) to 2 
data sets
Quality Rating: 








Study (3 pts 
maximum): 2;
- Study Setting: 
Sufficiently 
distinctive that results 
may not be 
generalizable to other 
settings/specimens – 
Surg. path. workflow 
redesign
Practice (2 pts 
maximum): 2
Outcome measures 
(2 pts maximum): 2
Results/findings (3 
pts maximum): 3
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- Facility: Lyndon B 
Johnson hospital, 
Houston, TX, >300 
bed teaching hospital.; 




department and all 
nursing units except 





- Time Period: 
1/1/2009 – 8/31/2009
Pre: 1/2009 – 4/2009 
(4 mos.)
Post: 6/2009 – 8/2009 
(3 mos.)
- Sample: Inpatient 




Phlebotomists use of a 
printed draw list and 
pre-printed specimen 
label to enter 
collection information 
(date/time & ID of 
patient)
- Study bias: 









labels from wireless 
handheld printer and 
label specimen tubes 
by the patients’ 
bedside; in use 24/7. 




- Training: Staff 
training takes 3 hours 
to learn equipment 
use
- Staff: 20 
phlebotomists, IT 
facility staff for 
installs and training
- Cost: Cost related to 
training 
phlebotomists: $14.20 
* 3 hours * 20 FTEs =




and training) = $1 
million for district (2 
















Pre: review of 
occurrence log 







Pre: 0.012%, (5 / 41, 
815)

























Study (3 pts 
maximum): 2; 
Potential study bias –
Sample selection 
using phlebotomists 
only with low initial 
error rates.
Practice (2 pts 
maximum): 2
Outcome 
measures (2 pts 
maximum): 2
Results/findings (3 
pts maximum): 2;- 
Sample sufficiency: 
Small number of 
errors reported yields 














- Facility/ Setting: 
UMN Fairview, 
Minneapolis, MN; 
>300 bed academic 
medical center; > 
1,000,000 tests/yr.
- Study Setting: 
Clinical lab, EDs, 
- Description: 
Barcoding system for 
patient ID using hand-
held PC to verify 
specimen labels 
match wristband prior 
to labeling specimen 
tubes at the bedside. 
No mention of CPOE.




















Units with Barcoding 
system: 0.4 errors/
10,000 collections
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Adult ICUs, Pediatric 
PCUs
- Time Period: 
Multiple study arms/
start dates in various 
units: Clinical lab: 
6/2006–8/2009; Univ. 
campus ED 7/2006– 
8/2009; select PCUs-
pilot only: 11/2006–
2/2007; Riverside and 
behavioral ED: 2/2007 
–8/2009; Adult ICUs: 
2/2008–8/2009.
- Sample: 100% of 
specimen containers; 
numbers and dates not 
reported. Total 
volume: 39,300 / 
month.
- Comparator: No 
details reported for 
practice
- Study bias: Time 
period and sample 
selection methods 
may introduce bias 
affecting results
implementation as 
indicated in under 
Study Period).
- Training: ~30 min. 
for users
- Staff: Lab in 
collaboration with 
nursing and IT staff to 




- Cost: Start-Up: 
Design & 
programming cost: 
$600,000; hardware : 
~ $425,000
Post Start-Up: ~















event tracking logs, 
and compared to 
“cancel comments” 
in lab computer 
system). 
Compliance (scan 
rate) based on 
monthly 1-day 








biases: Sample sizes 
and specific dates not 
reported. Results not 
specified by medical 
unit (i.e., with/without 
barcoding system vs. 
those not reported), 
and different 
recording methods 




Findings rating = 







Study (3 pts 
maximum): 1; - 
Potential study bias: 
Study sample and 
selection methods 
may introduce a study 
bias substantially 
affecting results - 
Sample not adequately 
described and sample 
selection may be 
biased (when practice 
used “compliantly”)
Practice (2 pts 
maximum): 2
Outcome 
measures (2 pts 
maximum): 2
Results/findings (3 
pts maximum): 0; - 
Sample sufficiency: 
Measurement period, 
# tests and errors not 
reported (−2) - 
Appropriateness of 
statistical analysis: 
Insufficient data to 
allow/verify 
calculation of effect 
size (−1) and different 
recording method 


























- Time Period: 
12/1/2007 – 8/2009
Pre: 12/2007 11/2008 
(1 yr.)
Post: 12/2008– 8/2009 
(9 mos.)
- Sample: Primary 
cassettes/blocks 
derived from patient 
specimens (outpatient 
-Barcoding system to 
identify and track all 
specimens from 
accessioning to gross 
station, and just-in-
time, single piece 




read at grossing 
station and user 
specifies number of 
cassettes to produce 
and then computer 
prints 2D barcoded 
cassettes requiring 

















Savings – estimate 
of labor hours 









Pre: 1.16% (988 / 
85,213 )






➢ OR = 147 (CI: 55 
– 391)
(2) Post-practice: 
saved 0.75–1.0 FTE 
gross room personnel 
(less material 
handling, less error 
resolution efforts), not 
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- Comparator: Not 
described
- Study bias: None 
noted for error rate 
measure.
- Duration: 9 months 
(12/1/08– 8/2009), 
ongoing
-Training: End User 
Training for 
permanent gross room 
personnel and rotating 
pathology residents




- Cost: Software 
custom~$200,000; 4 
cassette printers @ 
$20,000 each = 
$80,000; Hardware: 
PCs, barcode readers, 
label printers, 
mounting arms = 
$8,000 (US$ 2008)










(2) Survey of gross 
room personnel – 
estimates of time 
saved due to 
barcoding system









savings based on user 
recall (no point 













Study (3 pts 
maximum): 2; - 
Study Setting: 
Sufficiently distinctive 
that results may not be 
generalizable to other 
settings /specimens – 
Anat. path. gross room 
process- derived 
specimen cassettes
Practice (2 pts 
maximum): 2
Outcome 
measures (2 pts 
maximum): 2
Results/findings (3 




methods used during 
for pre and post 
periods for measuring 
and comparing errors 
(−2)
Unpublished 














- Facility: Academic 
medical center in 
Western U.S.; >300 
beds; > 1,000,000 lab 
tests/yr.
- Setting: Inpatient 
non-ICU units where 
blood collected by 
clinical lab 
phlebotomy team
- Time Period: 1/1/06 
– 7/31/2009: Pre: 1–
12/2006 (1 year); 
Post: 1/2007–7/2009)
- Sample: All 
phlebotomist inpatient 
blood specimens 
(sample size not 
reported); approx. 
33% of 29,000/mo. 














using patient bedside 
barcode specimen 
labeling with wireless 
handheld device and 
attached mini-barcode 
label printer. The 
device can access the 
patient test orders in 
real time, collect 
orders, and print test 
labels at the patient 




-Training: 3 trainers 
provided directly 
from system vendor 
and 2 FTEs from 
clinical laboratory IT; 
no time-related 
information
- Staff: Clinical lab 
team: 1 FTE 
phlebotomy 
supervisor; 20 FTEs 
for 24/7 blood draws








Note: error rate 













Size: PSID Error Rate 
(calculated using 
above PSID errors 
using estimated 
sample size of 
114,840/ yr.):
Pre: 12/114,840 = 
0.010%






➢ OR = 12.00 (CI: 
1.56 92.3)
Total (annual) PSID 
errors reported
Pre (2006): 12 errors
Post: 2007: 1 error
2008: 0 errors;
2009: 0 errors 
(through 7/09).
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- Comparator: Status 














Study (3 pts 
maximum): 1; 
Potential study bias: 





12/2006 in Pre period 
(−1)
Practice (2 pts 
maximum): 2;
Outcome 
measures (2 pts 
maximum): 1; - 
Recording method: 
May not accurately 
capture all instances 
of the outcome
Results/findings (3 
pts maximum): 2; - 
Sample sufficiency: 
Small number of 
errors reported yields 
unstable effect size 
estimate
Laboratory Medicine Best Practices Body of Evidence Table
TOPIC AREA: Patient Specimen Identification
Practice: Point-of-Care Test Barcoding
Practice: POCT Bar
Coding Systems








EvidenceStudy Practice Measures Results Total Rating
Colard 2005 3 2 1 2 8 Good Substantial
Nichols et. al 2004 2 2 1 0 5 Poor N/A
















Hospital Buffalo 2011 3 2 2 3 10 Good Substantial
Sisters of Charity
Hosp. St. Joseph 2011 3 2 2 3 10 Good Substantial
Unpub B 2009 1 2 2 0 5 Poor N/A Yes High
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- Point of Care




- Funding: not 
reported
- Design: Before-after
- Facility/Setting: Saint 
Luke’s Hospital, Kansas 
City, MO; 629-bed 
tertiary care teaching 
hospital for Univ. of 
Missouri - Kansas City 
School of Med.
- Time Period: 12/2002 
– 12/2003
Pre: 1 mo. (11/2002)
Post: 9 mos. (4/2003 – 
12/2003)
Implementation: 4 mos. 
(12/2002–3/2003); scan 
rates <75%.
- Sample: All inpatient 
point-of- care glucose 
tests during study period. 
No data provided for # 
tests or tests/mo. Used 
for study. Before 
implementation: ~12,000 
tests/mo.; at end of study 
period: >15,000 tests/mo.
- Comparator: Manual 
entry of patient ID and 
test results with a 
scripted interface to the 
LIS. Glucose meter 
without optional barcode 
wand.














Provided to all 
nursing staff; those 



















affecting early scan 
and error rates 
including change 
in symbology/
reduction in width 
of bar code 
(2/2003), new 






scan rate ranged 
from 76% (4/2003) 
to ≥ 90% (6/2003–
12/2003).
- Description:
(1) Patient ID 
Error Rate - % 
patient 
identification 























➢ OR = 14.72 (CI: 
13.47 – 16.08)
(2) # ID Errors/







Bias: Data presented as 
reported above however 




training” - 5/2004: (1) 
ID Error Rate: 0.18%; 
(2) 6 errors. Not 
included as no data 
reported for 1/2003–
4/2004).
* Sample size not 
explicitly reported; 
effect size calculated 
based on authors’ 











Study (3 pts 
maximum): 3
Practice (2 pts 
maximum): 2
Outcome 






Results/findings (3 pts 
max.): 2; - 
Appropriateness of 
statistical analysis; Does 
not provide data 
sufficient to allow/verify 
calculation of an effect 
size– sample size (−1)
Nichols JH [1,2], 
Bartholomew C 
[2], Brunton M 
[2], Cintron C 
- Design: Before-After






code and 9-digit 
- Description: # 
POCT Patient 
ID errors per 
month (count):
- Pretest-Posttest:
- Findings/Effect Size: 
Identification errors
(1)Glucose meter
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[2], Elliott S [2], 
McGirr, J [2], 
Morsi, D [2], 
Scott, S, Seipel, J 















network, western MA; 3 
hospitals; > 850 beds; 
(Baystate Med. Ctr., 
Franklin Med. Ctr., Mary 
Lane Hospital).
- Time Period: 1/ 2002–
1/2004
Pre: 10 mos. (1/2002–
10/2002)
Post: 15 mos. (11/2002– 
1/2004)
- Sample: All Intensive 
Care Unit (ICU) blood 
gas and glucose POCTs 
for all 3 hospitals; annual 
system-wide volume 
~600,000 glucose and 
blood gas tests.
- Comparator: POCT 
with manual entry of 
patient ID and operator 
code with operator lock 
out “3-Strike Rule” for 
ID entry errors (began 
6/2002)
- Study Bias: Operator 
problems reading 
barcoded wristbands in 




- Duration: 15 
months (11/2002 – 
1/2004); ongoing


























Pre: 26 / month




Post: 1.7 / month* (p = 
0.048)
➢ OR: N/A due to 
insufficient data
*Included one patient 
with 11 errors in one 




Test(s): Not reported; p-
values provided
- Results/Conclusion 
Bias: Sample sizes or 
monthly volumes not 
provided for ICU POC 












Study (3 pts 
maximum): 2 - Potential 
study bias: Study time 
period and sample may 
introduce bias 
substantially affecting/
understating results – 
Operator problems in 
post months (−1)
Practice (2 pts 
maximum): 2
Outcome 
measures (2 pts 




test volume is 
not error rate 
outcome (−1)
Results/findings (3 pts 
maximum): 0; - Sample 
sufficiency: Number of 
tests not reported (−2); - 
Appropriateness of 
statistical analysis: Does 
not provide data to 
allow/verify calculation 
of effect size rate 
(sample size not 
reported) (−1)
Rao, AC; Burke, 
DA; and Dighe, 
AS [1]
- 2005








Boston, MA; 900-beds; 
largest teaching hospital 
of Harvard Medical 
School and hospital- 
based research program
- Time Period: No dates 
reported; 1 month pilot 
test of barcoding with 2 
months of comparator (1 
Pretest and 1 Post test)
- Sample: 35 inpatients 
included in pilot test of 
bar coding only - 462 
total glucometry tests:
- Pre: 170 (no barcoding)
- Pilot: 158 (barcoding)
- Post: 134 (no 
barcoding)
- Comparator: Usual 
Care - POC device with 
- Description: 
POCT Barcoding 
2D bar code for 
patient wristbands; 
only the medical 
record number 
included in the ID 
bar code which is a 
unique identifier 
for each patient.
- Duration: 1 
month (pilot test 
only)




assistants on how 





Patient ID error 












No Barcoding: 1.32% 
(4/304)*
Barcoding Pilot test: 0% 
(0/158)
*( Pretest and Posttest 
combined: Pretest: 1.2% 





➢ OR = 4.75 (CI: 0.25 
– 88.73) (Results for 2 
comparator periods 
pooled)
- Stat Significance/ 
Tests: Difference in 
error rates was 
statistically significant 
by Chi- squared analysis 
(P<0.005).
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keypad for manual 
patient ID data entry
- Study Bias: Pilot test 
limited sample
- Cost: Not 
reported
- Results/Conclusions 
Biases: Study period is 
short, 1 month; 












Study (3 pts 
maximum): 2; Potential 
study bias: The study 
design, time period and 
sample selection methods 
may introduce study bias 
substantially affecting 
results – limited to 35 
inpatients (−1)
Practice (2 pts 
maximum): 2
Outcome 
measures (2 pts 




Results/findings (3 pts 
maximum): 2; - Sample 
sufficiency: 
Measurement period and 
sample size may be too 
small/insufficient to 
allow a robust estimate 
of the impact of a 
practice (-1)

























































Center, Danville, PA; 




Baseline - early 




1/2009 – 6/2009 (6 
mos.)
- Sample: Inpatient 
point-of- care glucose 
tests
Baseline: ~ 18,000/mo. 
(avg.)
Barcoding: 106,780
- Comparator: Initial 
stage barcode POCT 
implementation (2002–
2004) compared to full 
implementation (2007–
2009).
- Study Bias: Baseline 
sample data include ~ 
- Description: POCT 
(point-of- care test) 
Barcoding with 
ongoing reporting of 
barcoding procedure 
compliance (scan 
rate) and patient ID 
errors to nursing 
management.
- Duration: 9/2002- 
6/2009; ongoing
- Training: 
Education of nursing 




“scan only” on each 
meter, and laminated 
scanning guidelines 
cards were attached 










Patient ID error 




* Monthly average 














all scanning devices 
for audit reports; 
documentation of 























show effect of 
improving 
implementation of 
POCT barcoding as 
reflected in average 
scan rates from 
31.8% versus 96.7%.
Limitation: 
comparison based on 
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1/3 barcoding practice 
(less-than-full 
implementation), as 
error reporting began 
1/2004.
reporting after low 
scan rates (<1/3) and 
high ID errors
data collected during 
notably different time 











Study (3 pts 
maximum): 2;
- Potential study bias: 
Study design, time 
period and sample may 
introduce bias 
affecting/understating 
effect size - Baseline 
period includes ~1/3 
barcoding (−1).
Practice (2 pts 
maximum): 2
Outcome measures 






Data provided not 
sufficient to verify 
calculation of effect 




effect size reported 
includes barcoding in 
both baseline (~1/3) 





















NY; teaching hospital; 
100- 300 beds
- Time Period: 
1/1/2007 – 5/31/2011
Pre: 16 mos. (1/2007 – 
4/2008)
Post: 37 mos. (5/2008 
– 5/2011)







- Comparator: Patient 
wristband with typed 
patient identifying 
information (name, 
date of birth, medical 
record number)
- Study bias: None 
noted
- Description: POC 
glucose tests with 






- Training: Training, 
re-training and 
communication/
feedback using data 




implemented as an 
upgrade to pharmacy 
barcoding which first 
introduced nurses to 
the process of 





- Cost: Not reported
- Description: 
Patient ID error rate 
(%): # Patient ID 
errors/total # POC 
glucose tests (Error: 
Patient ID # from 







audit of daily 
testing log flags ID 
#s not matched to 
patients. Monthly 
review of ID errors 











Patient ID error rate


























Study (3 pts 
maximum): 3
Practice (2 pts 
maximum): 2
Outcome measures 









Mercy Hospital of 
Buffalo, Buffalo, NY; 
- Description: POC 
glucose tests with 
barcoded patient ID 
- Description: 
Patient ID error rate 
(%): # Patient ID 
errors/total # POC 
Pretest-Posttest
Findings/Effect Size: 
Patient ID error rate
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teaching hospital; > 
300 beds
- Time Period: 
1/1/2007 – 5/31/2011
Pre: 17 mos. (1/2007 – 
5/2008)
Post: 36 mos. (6/2008 
– 5/2011)







- Comparator: Patient 
wristband with typed 
patient identifying 
information (name, 
date of birth, medical 
record number)







- Training: Training, 
re-training and 
communication/
feedback using data 




implemented as an 
upgrade to pharmacy 
barcoding which first 
introduced nurses to 
the process of 





- Cost: Not reported
glucose tests (Error: 
Patient ID # from 







audit of daily 
testing log flags ID 
#s not matched to 
patients. Monthly 
review of ID errors 



































Study (3 pts 
maximum): 3
Practice (2 pts 
maximum): 2
Outcome measures 




Sisters of Charity 
Hospital Buffalo, 
Catholic Health 














Sisters of Charity 
Hospital, Buffalo, NY 
teaching hospital; 100- 
300 beds
- Time Period: 
1/1/2007 – 5/31/2011
Pre: 17 mos. (1/2007 – 
5/2008)
Post: 36 mos. (6/2008 
– 5/2011)







- Comparator: Patient 
wristband with typed 
patient identifying 
information (name, 
date of birth, medical 
record number)
- Study bias: None 
noted
- Description: POC 
glucose tests with 






- Training: Training, 
re-training and 
communication/
feedback using data 




implemented as an 
upgrade to pharmacy 
barcoding which first 
introduced nurses to 
the process of 





- Cost: Not reported
- Description: 
Patient ID error rate 
(%): # Patient ID 
errors/total # POC 
glucose tests (Error: 
Patient ID # from 







audit of daily 
testing log flags ID 
#s not matched to 
patients. Monthly 
review of ID errors 











Patient ID error rate
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Study (3 pts 
maximum): 3
Practice (2 pts 
maximum): 2
Outcome measures 

























Sisters of Charity 
Hospital St. Joseph’s 
Campus, 
Cheektowaga, NY; 
teaching hospital; 100- 
300 beds
- Time Period: 
1/1/2007 – 5/31/2011
Pre: 11 mos. (1/2007 – 
11/2007)
Post: 42 mos. 
(12//2007 – 5/2011)







- Comparator: Patient 
wristband with typed 
patient identifying 
information (name, 
date of birth, medical 
record number)
- Study bias: None 
noted
- Description: POC 
glucose tests with 






- Training: Training, 
re-training and 
communication/
feedback using data 




implemented as an 
upgrade to pharmacy 
barcoding which first 
introduced nurses to 
the process of 





- Cost: Not reported
- Description: 
Patient ID error rate 
(%): # Patient ID 
errors/total # POC 
glucose tests (Error: 
Patient ID # from 







audit of daily 
testing log flags ID 
#s not matched to 
patients. Monthly 
review of ID errors 











Patient ID error rate


























Study (3 pts 
maximum): 3
Practice (2 pts 
maximum): 2
Outcome measures 






















Teaching Hospital with 
affiliated clinic sites; > 
300 beds.
- Time Period: 
1/1/2009 – 6/30/2009;
Pre: 1st Quarter 2009 
(1/1/2009 – 3/31/2009) 
– 3 mos.
- Description: POCT 
barcoding for 
glucose tests by 
adding a barcode to 
the patient armband 





- Training: Training 
needs are modest – 
time to train all 
glucose users on new 
- Description: 
Patient ID error rate 
(%): POC glucose 
test results with 
either incorrectly 
entered (miskeyed) 
patient ID or 
reported on the 















➢ OR = 1.59 (CI: 
0.85 – 2.99) (Note: 
Denominator of rate 
estimated from data 
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Post: 2nd Quarter 2009 
(4/1/09 – 6/30/09 ) – 3 
mos.
- Sample: All inpatient 
and outpatient bedside 
POC glucose tests; 




patient armband to 
glucose work list




process; support for 
barcode accessories; 
on-going training on 
policy and process 
updates.
- Staff/Other 
Resources: Time to 
identify & test new 
armband- materials 
barcodes, develop 
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Systematic Review Flow Diagram
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Figure 3. Meta-Analysis Forest Plot: Barcoding Systems
Each box represents the mean odds ratio for an individual study indicated to the far left, with 
the box size proportional to the study sample size. The endpoints of the lines on the left and 
right sides of the box represent the lower and upper limits, respectively, of the study odds 
ratio’s 95% confidence interval, with the numerical values provided to the left. The bottom 
line represents the overall summary effect (or grand mean) for all the studies in the body of 
evidence along with its confidence interval. In addition, meta-analysis results were tabulated 
separately for two subgroups using the two study quality ratings “Fair” and “Good.”
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Meta-Analysis Forest Plot: Point-of-Care Test Barcoding
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Table 1
Body of Evidence Summary Table: Barcoding Systems
Study (Quality and 
Effect Size Ratings) Population/Sample Setting Time period









Ridgewood, NJ; >400 
beds); 10 care centers
Pre: 1/1999– 12/1999











Inpatient blood specimens 
from 6 care units (3 med/
surg., intermediate, 






Columbia, MD: 227- 
bed, nonprofit acute 
care community 
hospital
Pre: 11/2005 – 
10/2006
Post: 11/2006 – 
10/2007
Specimen labeling error 









All tissue and body fluid 
test order events 
(accessions)
Pre: 19,247/mo. (1 yr.)
Post: 17,793/mo. (1 yr.)














All emergency department 






MD; Academic medical 
center; Adult 
emergency department
Pre: 9/2004 – 4/2008
Post: 5/2008 – 9/2009
Specimen processing error 
rate (unlabeled, mislabeled, 













UCSD Medical Center, 




Two 6 month periods 
for Pre and Post – no 
dates
PSID Error Rate per 1,000 
(misidentified, unlabeled, 
or mislabeled specimens):
Pre: 2.56 [CI: 1.94 −3.32]
Post: 0.49 [CI: 0.24 −0.87]









Brigham and Women’s 





Labeling error rate per 














Note: Other outcomes 
reported require more 
specimen processingb

























Univ of WA c 2009
• Fair
Univ of WA c 2009 Univ of WA c 2009 Univ of WA c 2009 Univ of WA c 2009
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Study (Quality and 
Effect Size Ratings) Population/Sample Setting Time period
Results (Specimen ID 
Error Rates)




















Number of blood samples not provided in published article; provided in direct e-mail communication received 7/12/2011 from Susan Neal-
Lyman.
b
Additional measures: specimen parts, tissue cassettes, and histology slide labels
c
Excluded from meta-analysis
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Table 2
Body of Evidence Summary Table: Point-of-Care Test Barcoding
Study (Quality and Effect 
Size Ratings) Population/Sample Setting Time period





All inpatient glucose POCT- 
approximately 12,000–
15,000/mo. (no data 
provided for study sample)
Saint Luke’s Hospital, 
Kansas City, MO; 
629-bed tertiary care 
teaching hospital
11/2002 – 12/2003
Pre: 1 mo. (11/2002)
Post: 9 mos. (4–
12/2003)















teaching hospital, > 
900 beds
No dates reported
No Barcoding: 2 
mos.
Barcoding: 1 mo.
Patient ID Error rate
No Barcoding: 1.32%
Barcoding: 0.00%






Glucose POCTs for all 
inpatients; ~18,000/mo.; 
Baseline sample size not 




Center, Danville, PA; 




Baseline: 1 mo. 
(2004)
Barcoding: 6 mos. 
(2009)








All hospital inpatient and 











Patient ID Error rate
Pre : 2.16%
Post: 0.57%




All hospital inpatient and 




Mercy Hospital of 






Patient ID error rate
Pre : 2.24%
Post: 0.44%




All hospital inpatient and 




Sisters of Charity 
Hospital, Buffalo, 





Patient ID error rate
Pre : 1.56%
Post: 0.42%
OR = 3.75 (CI: 3.48 – 4.04)
Sisters. St. Joseph 2011
• Good
• Substantial
All hospital inpatient and 




Sisters of Charity 








Patient ID error rate
Pre : 3.22%
Post: 0.54%
OR = 6.09 (CI: 5.61 – 6.60)
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